| 注册
首页|期刊导航|国际医药卫生导报|非结核分枝杆菌临床药敏结果分析

非结核分枝杆菌临床药敏结果分析

史立秋

国际医药卫生导报2017,Vol.23Issue(3):384-386,3.
国际医药卫生导报2017,Vol.23Issue(3):384-386,3.DOI:10.3760/cma.j.issn.1007-1245.2017.03.029

非结核分枝杆菌临床药敏结果分析

Clinical drug susceptibility results of non-tuberculous mycobacteria

史立秋1

作者信息

  • 1. 121017 锦州市传染病医院
  • 折叠

摘要

Abstract

Objective To effectively understand the changes in non-tuberculosis mycobacteria and its drug resistance testing its drug sensitivity and analyzing the results.Methods 196 strains of non-tuberculosis mycobacteria isolated from the sputum and bronchial washing fluid of the patients with lung disease treated at our hospital from July,2013 to June,2015 were selected.The bacteria species and drug resistance were analyzed.Results The macteria mainly were mycobacterium avium-intracellulare,mycobacterium chelonei,mycobacterium chelonei and fortuitum complex,and Mycobacterium smegmatis,accounting for 31.6%,17.3%,14.8%,and 12.2%.Mycobacterium chelonei,mycobacterium chelonei and fortuitum complex,mycobaeterium avium-intracellulare,and Mycobacterium smegrnatis were sensitive to clarithromycin.The drug resistance rates of non-tuberculous mycobacteria to rifampin,streptomycin,isoniazid,ethambutol,levofloxacion,moxifloxacin,and protionamid were all over 60.0%.Conclusions Drug sensitive test for non-tuberculosis mycobacteria has important significance for elinicans choosing medicine treatment and improving treatment effect.

关键词

分布/菌种/抗菌药/非结核分枝杆菌/耐药性

Key words

Distribution/Bacteria species/Antibiotics/Non-tuberculosis mycobacteria/Drug resistance

引用本文复制引用

史立秋..非结核分枝杆菌临床药敏结果分析[J].国际医药卫生导报,2017,23(3):384-386,3.

国际医药卫生导报

1007-1245

访问量0
|
下载量0
段落导航相关论文